poudre pour solution à diluer pour perfusion

DRUG2 trials

Sponsors

Lysarc, Assistance Publique Hopitaux De Marseille

Conditions

Relapsed or Refractory Marginal Zone Lymphomasurgical antibiotic prophylaxis

Phase 3

MARSUN: Phase III, Multicenter, Open label, Randomized, Controlled Study Investigating Mosunetuzumab-Lenalidomide versus investigator choices in Patients with Relapsed or Refractory Marginal Zone Lymphoma

RecruitingCTIS2022-501810-77-00

LysarcRelapsed or Refractory Marginal Zone Lymphoma

Start: 2023-09-01Target: 260Updated: 2025-09-22

Linezolid or vancomycin surgical site infection prophylaxis LOVip

RecruitingCTIS2023-504986-22-00

Assistance Publique Hopitaux De Marseillesurgical antibiotic prophylaxis

Start: 2024-09-30Target: 1160Updated: 2025-12-12

Linezolid or vancomycin surgical site infection prophylaxis LOVip

RecruitingCTIS2023-504986-22-00

Assistance Publique Hopitaux De Marseillesurgical antibiotic prophylaxis

Start: 2024-09-30Target: 1160Updated: 2025-12-12